Shedding light on disease at Imperial

Working with a world-leading pharmaceutical company to improve our understanding of serious illnesses

The GSK-sponsored clinical imaging centre at Imperial College London is a multi-million pound collaboration which has created a world-leading facility drawing on the research expertise of Imperial College.

GlaxoSmithKline committed to a £50m investment in the centre, which officially opened in 2007. Alongside parallel investment from Imperial College and the Medical Research Council, GSK’s commitment has equipped the centre with state of the art scanning and imaging facilities, which will enable scientists to improve their understanding of some of the world’s most serious diseases, including cancer, cardiovascular disease and neurological disorders. Through improving fundamental understanding of diseases, it will create a platform for the development of new, more effective, treatment and prevention.